Mary Helen Hackney

505 total citations
20 papers, 245 citations indexed

About

Mary Helen Hackney is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mary Helen Hackney has authored 20 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mary Helen Hackney's work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and Cardiac Imaging and Diagnostics (3 papers). Mary Helen Hackney is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and Cardiac Imaging and Diagnostics (3 papers). Mary Helen Hackney collaborates with scholars based in United States and Poland. Mary Helen Hackney's co-authors include Thomas J. Smith, Jennifer S. Myers, David A. Gewirtz, Victor Yazbeck, Laurie W. Cuttino, Erin R. Alesi, Laurie Lyckholm, Christopher E. Desch, James E. Shaw and Alison Conlin and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Mary Helen Hackney

18 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Helen Hackney United States 10 102 50 33 33 27 20 245
Omar Khan Canada 13 97 1.0× 35 0.7× 32 1.0× 52 1.6× 48 1.8× 28 314
Jared D. Acoba United States 12 171 1.7× 35 0.7× 80 2.4× 45 1.4× 50 1.9× 39 345
Meaghan Krohe United States 9 109 1.1× 31 0.6× 47 1.4× 37 1.1× 59 2.2× 19 336
Gülten Oskay-Özcelik Germany 11 122 1.2× 23 0.5× 82 2.5× 41 1.2× 24 0.9× 32 352
Livio Blasi Italy 11 189 1.9× 45 0.9× 51 1.5× 25 0.8× 89 3.3× 49 377
Leigh Boehmer United States 9 96 0.9× 17 0.3× 47 1.4× 53 1.6× 64 2.4× 42 253
E. Mayer United States 3 109 1.1× 27 0.5× 24 0.7× 48 1.5× 58 2.1× 5 498
Xianhua Mao China 9 86 0.8× 39 0.8× 71 2.2× 32 1.0× 57 2.1× 18 454
Meagan Miller United States 5 84 0.8× 52 1.0× 106 3.2× 13 0.4× 104 3.9× 16 311
Iyar Mazar United States 9 93 0.9× 24 0.5× 66 2.0× 23 0.7× 49 1.8× 20 313

Countries citing papers authored by Mary Helen Hackney

Since Specialization
Citations

This map shows the geographic impact of Mary Helen Hackney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Helen Hackney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Helen Hackney more than expected).

Fields of papers citing papers by Mary Helen Hackney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Helen Hackney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Helen Hackney. The network helps show where Mary Helen Hackney may publish in the future.

Co-authorship network of co-authors of Mary Helen Hackney

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Helen Hackney. A scholar is included among the top collaborators of Mary Helen Hackney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Helen Hackney. Mary Helen Hackney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bear, Harry D., Dipankar Bandyopadhyay, Michael O. Idowu, et al.. (2024). Abstract PO1-18-04: Neoadjuvant pembrolizumab + decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2- breast cancer (NCT02957968). Cancer Research. 84(9_Supplement). PO1–18. 2 indexed citations
2.
Thomas, Alexandra, Nathaniel S. O’Connell, Carolyn J. Park, et al.. (2023). Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study. American Heart Journal. 267. 33–43. 2 indexed citations
3.
D’Agostino, Ralph B., Jennifer H. Jordan, Amy C. Ladd, et al.. (2023). Accuracy of Rapid Cardiovascular Magnetic Resonance Assessment of Left Ventricular Function During Community Cancer Cardiotoxicity Surveillance (WF98213). The American Journal of Cardiology. 205. 204–206.
4.
O’Connell, Nathaniel S., Ralph B. D’Agostino, Jennifer H. Jordan, et al.. (2022). PRIOR TO CANCER TREATMENT, DO WOMEN WITH BREAST CANCER EXPERIENCE REDUCED AORTIC DISTENSIBILITY IN THE ABSENCE OF HYPERTENSION?. Journal of the American College of Cardiology. 79(9). 1883–1883.
5.
Yazbeck, Victor, Erin R. Alesi, Jennifer S. Myers, et al.. (2022). An overview of chemotoxicity and radiation toxicity in cancer therapy. Advances in cancer research. 155. 1–27. 59 indexed citations
6.
Lee, Ju‐Whei, Howard A. Zaren, Rachel E. Lerner, et al.. (2022). Cluster-randomized trial to evaluate the implementation of reproductive health care in cancer care delivery in community oncology practices: Results from ECOG-ACRIN E1Q11.. Journal of Clinical Oncology. 40(16_suppl). 1519–1519. 1 indexed citations
7.
Reding, Kerryn W., Nathaniel S. O’Connell, Richard K. Cheng, et al.. (2022). LVEF decline in relation to body composition among women treated for breast cancer: WF-97415.. Journal of Clinical Oncology. 40(16_suppl). 10556–10556. 1 indexed citations
8.
Sheppard, Vanessa B., Arnethea L. Sutton, Alejandra Hurtado‐de‐Mendoza, et al.. (2021). Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study. Cancer Epidemiology Biomarkers & Prevention. 30(4). 699–709. 14 indexed citations
9.
Idowu, Michael O., Mary Helen Hackney, Margaret M. Grimes, et al.. (2017). Diagnosis and Management of Breast Tumors. 1 indexed citations
10.
Rafie, Carlin, et al.. (2014). Reaching Hard to Reach Populations with Hard to Communicate Messages: Efficacy of a Breast Health Research Champion Training Program. Journal of Cancer Education. 30(3). 599–606. 6 indexed citations
11.
Seidman, Andrew D., Alison Conlin, Ariadne M. Bach, et al.. (2013). Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer. Clinical Breast Cancer. 13(4). 239–246.e1. 29 indexed citations
12.
Conlin, Alison, C. Hudis, A M Bach, et al.. (2009). Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC). Journal of Clinical Oncology. 27(15_suppl). 1006–1006. 23 indexed citations
13.
Hackney, Mary Helen, et al.. (2008). Ovarian Suppression in the Management of Premenopausal Breast Cancer: Methods and Efficacy in Adjuvant and Metastatic Settings. Oncology. 75(3-4). 192–202. 6 indexed citations
14.
Sterling, Richard K., R. Todd Stravitz, Velimir A. Luketic, et al.. (2007). Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease. Haemophilia. 13(2). 164–171. 12 indexed citations
15.
Hackney, Mary Helen, et al.. (2002). Cortisol and testosterone responses to training and competition stress in ice-dance skaters a case study. 2002(1). 23–25. 1 indexed citations
16.
Carr, Marcus E., et al.. (2002). Enhanced Platelet Force Development Despite Drug-Induced Inhibition of Platelet Aggregation in Patients with Thromboanglitis Obliterans. Vascular and Endovascular Surgery. 36(6). 473–480. 18 indexed citations
17.
Lyckholm, Laurie, Mary Helen Hackney, & Thomas J. Smith. (2001). Ethics of rural health care. Critical Reviews in Oncology/Hematology. 40(2). 131–138. 15 indexed citations
18.
Arthur, Douglas W., Rupert Schmidt‐Ullrich, Richard B. Friedman, et al.. (1999). Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation. International Journal of Radiation Oncology*Biology*Physics. 44(2). 289–296. 20 indexed citations
19.
Smith, Thomas J., Christopher E. Desch, Mary Helen Hackney, & James E. Shaw. (1997). How Long does it Take to Get a “Do not Resuscitate” Order?. Journal of Palliative Care. 13(1). 5–8. 15 indexed citations
20.
Smith, Thomas J., Christopher E. Desch, Michael Grasso, et al.. (1996). The Rural Cancer Outreach Program: clinical and financial analysis of palliative and curative care for an underserved population. Cancer Treatment Reviews. 22. 97–101. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026